micro-community-banner
 
  • Saved

Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs-Protocols and Advice for the FDA to Meet the ALS Act Vision - PubMed

Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs-Protocols and Advice for the FDA to Meet the ALS Act Vision - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39337696/

Although decades of intensive drug discovery efforts to treat neurodegenerative disorders (NDs) have failed, around half a million patients in more than 2000 studies continue being tested, costing over USD...

The study suggests that the FDA should focus on improving drug bioavailability across the blood-brain barrier for neurodegenerative diseases, requiring proof of brain entry for IND approval and reconsidering biomarker reliance.

  • Saved

Fluid biomarkers in multiple sclerosis: from current to future applications - PubMed

Fluid biomarkers in multiple sclerosis: from current to future applications - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39444698/

Multiple sclerosis (MS) is an immune-mediated inflammatory and degenerative disorder of the central nervous system (CNS) with heterogeneous clinical manifestations. In the last decade, the landscape of cerebrospinal fluid (CSF)...

This article explores cerebrospinal fluid (CSF) and blood biomarkers for multiple sclerosis (MS), highlighting their role in diagnosis, prognosis, treatment monitoring, and personalized management, while addressing real-world challenges.

  • Saved

Factors Contributing to the Development of Neuropsychiatric Manifestations in Persons With Multiple Sclerosis: A Systematic Review - PubMed

Factors Contributing to the Development of Neuropsychiatric Manifestations in Persons With Multiple Sclerosis: A Systematic Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39246867/

Multiple sclerosis (MS) is the most common chronic demyelinating disease affecting the central nervous system (CNS) and is distinguished by neuroinflammation and neurodegeneration. It has four categories based on clinical...

This systematic review explores factors influencing neuropsychiatric manifestations in multiple sclerosis, including brain changes, immune mechanisms, socioeconomic, and individual factors, highlighting the need for further research to improve patient outcomes.

  • Saved

A case report and review of rheumatoid arthritis co-occurring with tuberous sclerosis complex, a rare occurrence - PubMed

A case report and review of rheumatoid arthritis co-occurring with tuberous sclerosis complex, a rare occurrence - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39391300/

Rheumatoid arthritis (RA) is a common autoimmune disease. Tuberous sclerosis complex(TSC) is a rare autosomal dominant disorder. We report a case of RA with TSC. The patient was a 46-year-old...

A 46-year-old woman with RA and persistent cough was diagnosed with TSC after further evaluation revealed lymphangioleiomyomatosis, angiomyolipomas, subependymal nodules, and other TSC features. Everolimus improved her symptoms.

  • Saved

Solitary atrial Rhabdomyoma in an infant with tuberous sclerosis: a case report and review of the literature - PubMed

Solitary atrial Rhabdomyoma in an infant with tuberous sclerosis: a case report and review of the literature - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38062408/

Despite CR's predominance in the ventricles, a diagnosis of rhabdomyoma should be kept in mind in the presence of a solitary atrial mass and PACs. Physicians should evaluate systemic findings...

A 7-day-old neonate with atrial fibrillation, PACs, and a right atrial rhabdomyoma was diagnosed with tuberous sclerosis complex (TSC) based on systemic findings, managed with anti-convulsants, and monitored without surgery.